In a patient with atrial fibrillation and a history of intracranial hemorrhage, which direct oral anticoagulant is most suitable to minimize bleeding risk?
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901211672739840 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | In patients with atrial fibrillation and a history of intracranial hemorrhage, apixaban may be a suitable option among direct oral anticoagulants due to a potentially lower risk of bleeding, though definitive evidence from head-to-head trials is lacking. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17879015 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | In a patient with atrial fibrillation and a history of intracranial hemorrhage, which direct oral anticoagulant is most suitable to minimize bleeding risk? Tripdatabase atrial fibrillation intracranial hemorrhage direct oral anticoagulant bleeding risk anticoagulation therapy cardiology haematology patient safety stroke prevention clinical decision-making In patients with atrial fibrillation and a history of intracranial hemorrhage, apixaban may be a suitable option among direct oral anticoagulants due to a potentially lower risk of bleeding, though definitive evidence from head-to-head trials is lacking. |
| title | In a patient with atrial fibrillation and a history of intracranial hemorrhage, which direct oral anticoagulant is most suitable to minimize bleeding risk? |
| topic | atrial fibrillation intracranial hemorrhage direct oral anticoagulant bleeding risk anticoagulation therapy cardiology haematology patient safety stroke prevention clinical decision-making |
| url | https://doi.org/10.5281/zenodo.17879015 |